Skip to main content
# Title Research Member Research Year
71 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
Dr. Mayada Fawzy Sedik Farghaly 2020
72 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

Prof. Ashraf Zeidan Abdalla Ahmed 2020
73 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

Dr. Hanaan Ahmed Mohammed Ahmed 2020
74 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
Dr. Abeer Elsayed Ali Ibrahim 2020
75 Predictive and Prognostic Factors for the Outcome of the Patients Receiving Pegylated Liposomal Doxorubicin for Advanced Breast Cancer Dr. Abeer Elsayed Ali Ibrahim 2020
76 Is survival with Conservative Breast Therapy becoming Superior to that with Modified Radical Mastectomy alone for the Treatment of Early Breast Cancer in this Era? Dr. Salah Mabrouk Khallaf Abd Rabou 2020
77 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
Dr. Mayada Fawzy Sedik Farghaly 2020
78 Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center Dr. Salah Mabrouk Khallaf Abd Rabou 2020
79 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

Dr. Amen Hamdy Zaki Ali 2020
80 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

Rabab Mohammed Mamdouh Abdelhameed 2020